They show that a specific protein can be used as a 'biomarker' to identify which patients with a rare type of non-Hodgkin lymphoma would benefit from a new class of cancer drug.
他们展示了一种可以当做“生物标记物”特殊的蛋白，鉴别出使用新型肿瘤药物有效的稀有类型非霍奇金淋巴瘤的病人。
They show that a specific protein can be used as a 'biomarker' to identify which patients with a rare type of non-Hodgkin lymphoma would benefit from a new class of cancer drug.
他们展示了一种可以当做“生物标记物”特殊的蛋白，鉴别出使用新型肿瘤药物有效的稀有类型非霍奇金淋巴瘤的病人。
应用推荐